| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |